Drugs Made In America Acquisition II Corp. (DMIIR) Valuation — DCF, Graham & Comparables

Drugs Made In America Acquisition II Corp. (DMIIR) — Price $0.07 Financial ServicesFinancial - Conglomerates — NASDAQ

Latest reported results:

Valuation dashboard for Drugs Made In America Acquisition II Corp. (DMIIR) with P/E 0.40, P/B 0.01, EV/EBITDA -5.24 and dividend yield 0.00%. DCF, Graham Number and Earnings Power Value models plus sector comparison against other Financial Services companies.

Drugs Made In America Acquisition II Corp. operates as a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The company was founded on August 23, 2024 and is headquartered in Fort Lauderdale, FL.

Analysis Summary

Trailing-twelve-month margins: gross margin 0.0%, operating margin 0.0%, net margin 0.0%.

At the current price of $0.07, DMIIR trades at a P/E of 0.40 and an ROE of 2.66%. Market capitalisation stands at $5M.

Balance sheet quality for DMIIR: current ratio of 0.1. A debt-to-equity below 1.0 typically signals conservative capital structure, while a current ratio above 1.5 indicates comfortable short-term liquidity.

Valuation Ratios

P/E Ratio0.40
Price / Book0.01
EV / EBITDA-5.24
Dividend Yield0.00%

Peer Comparison

SymbolCompanyMarket CapP/EP/BROE
DMIIRDrugs Made In America Acquisition II Corp.$5M0.400.012.7%
PWF-PZ.TOPower Financial Corporation$19.6B
0RH1.LKinnevik AB$16.6B0.65-9.3%
FRHCFreedom Holding Corp.$10.1B65.136.6811.0%
BIPHBrookfield Infrastructure Finance ULC 5 % Notes 2021-24.05.81 Global$5.7B24.011.386.0%
0OPN.LCompagnie de l'Odet$5.5B
HTHHilltop Holdings Inc.$2.2B14.431.067.5%

Price

Price$0.07
Market Cap$5M
ExchangeNASDAQ
CountryUS

Profitability

Return on Equity2.66%
Return on Invested Capital-0.28%
Return on Assets2.53%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%

Explore sector: Financial Services · Financial - Conglomerates

More sections of DMIIR: Overview · Financials · Statistics · Estimates · Technical · Ownership · News · Events

Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks